Evidence map›Paper›PMID 42749777›Full record

ArticleMolecular psychiatry2026

De novo variants in the poly(rC)-binding protein gene PCBP1 cause a neurodevelopmental disorder.

Wallid Deb, Thomas Besnard, Florence Desprez, Benjamin Cogné, Laura Do Souto Ferreira, Virginie Vignard, Sylviane Marouillat, Louis Januel, Svetlana Gorokhova, Tiffany Busa and 48 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

58 authors.

Wallid DebNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France. wallid.deb@chu-nantes.fr.ORCID http://orcid.org/0000-0002-5103-8573
Thomas BesnardNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France.ORCID http://orcid.org/0000-0003-4804-5147
Florence DesprezUniversité de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN, U1253, Tours, France.
Benjamin CognéNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France.
Laura Do Souto FerreiraNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France.
Virginie VignardNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
Sylviane MarouillatUniversité de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN, U1253, Tours, France.ORCID http://orcid.org/0000-0001-7918-9755
Louis JanuelGCS AURAGEN, Lyon, France.
Svetlana GorokhovaGCS AURAGEN, Lyon, France.ORCID http://orcid.org/0000-0001-6870-4061
Tiffany BusaMedical Genetics Department, Timone Children's Hospital, APHM, Marseille, France.
Victor MorelMedical Genetics Department, Timone Children's Hospital, APHM, Marseille, France.
Benjamin DauriatService de cytogénétique et génétique médicale, CHU Limoges, Limoges, France.
Vincent Des PortesCentre de Référence des Maladies Rares et Déficience Intellectuelle, HCL Université de Lyon, Service de Neuropédiatrie HFME, Lyon, France.
Eyyüp ÜçtepeAcibadem Labgen Genetic Diagnosis Center, Istanbul, Türkiye.
Özlem Akgün DoğanSchool of Medicine, Department of Pediatrics, Division of Pediatric Genetics, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.
Ahmet YeşilyurtAcibadem Labgen Genetic Diagnosis Center, Istanbul, Türkiye.
Yasemin AlanaySchool of Medicine, Department of Pediatrics, Division of Pediatric Genetics, Acibadem Mehmet Ali Aydinlar University, Istanbul, Türkiye.
Anne M SlavotinekDepartment of Pediatrics, University of California, San Francisco, CA, USA.ORCID http://orcid.org/0009-0004-4069-7778
Yu AnDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Hane LeeDepartment of Pathology and Laboratory Medicine, Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-4736-0412
Jessy HaryNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France.
Peter KannuDepartment of Medical Genetics, University of Alberta, Edmonton, AB, Canada.
Taryn B AtheyDepartment of Medical Genetics, University of Alberta, Edmonton, AB, Canada.
Ingrid M B H van de LaarDepartment of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Marjon A van SlegtenhorstDepartment of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Patricia DicksonDepartment of Pediatrics, Washington University School of Medicine, 660 S. Euclid, Saint Louis, MO, 63110, USA.
Rachel SlaughDepartment of Pediatrics, Washington University School of Medicine, 660 S. Euclid, Saint Louis, MO, 63110, USA.
Fadi F HamdanCentre de Recherche Azrieli du CHU Sainte-Justine, Montreal, QC, Canada.
Jean-François SoucyDivision of Medical Genetics, Department of Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada.
Jacques L MichaudCentre de Recherche Azrieli du CHU Sainte-Justine, Montreal, QC, Canada.ORCID http://orcid.org/0000-0002-9912-0293
Alison M MuirGeneDx, LLC, Gaithersburg, MD, 20877, USA.
Rebecca BuchertInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0001-7576-3326
Tobias B HaackInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0001-6033-4836
Dominic ImortDepartment of Pediatrics, Allgemeines Krankenhaus Celle, Celle, Germany.
Sérgio B SousaMedical Genetics Unit, Hospital Pediátrico, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
Belinda Campos-XavierMedical Genetics Unit, Hospital Pediátrico, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
Pedro M AlmeidaMedical Genetics Unit, Hospital Pediátrico, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
Borut PeterlinClinical Institute for Genomic Medicine, University Medical Center Ljubljana, Ljubljana, Slovenia.
Sophie KasparInstitute of Human Genetics, University Hospital Cologne, Cologne, Germany.
Christian NetzerInstitute of Human Genetics, University Hospital Cologne, Cologne, Germany.
Hans ZempelInstitute of Human Genetics, University Hospital Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-7510-3077
Meghan C TowneAmbry Genetics, Aliso Viejo, CA, USA.
Roger L LaddaPenn State Health Golisano Children's Hospital, Department of Pediatrics, Division of Human Genetics, Hershey, PA, USA.
Susan L SellPenn State Health Golisano Children's Hospital, Department of Pediatrics, Division of Human Genetics, Hershey, PA, USA.
Lina QuteinehMedigenome, Swiss Institute for Genomic Medicine, 1207, Geneva, Switzerland.
Romane MeursMedigenome, Swiss Institute for Genomic Medicine, 1207, Geneva, Switzerland.ORCID http://orcid.org/0000-0003-3115-2501
Stylianos E AntonarakisMedigenome, Swiss Institute for Genomic Medicine, 1207, Geneva, Switzerland.
Pawel GawlinskiInstitute of Mother and Child, Kasprzaka 17a, 01-211, Warsaw, Poland.
Xiaofei SongDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-6585-7318
Wojciech WiszniewskiInstitute of Mother and Child, Kasprzaka 17a, 01-211, Warsaw, Poland.
Daniel G CalameSection of Pediatric Neurology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030, USA.
Jennifer E PoseyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Frederic EbsteinNantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0001-9907-9246
Bertrand IsidorNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France.
Stéphane BézieauNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France.ORCID http://orcid.org/0000-0003-0095-1319
Frédéric Laumonnier *Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN, U1253, Tours, France.ORCID http://orcid.org/0000-0003-2567-0708
Sébastien Küry *Nantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France. sebastien.kury@chu-nantes.fr.ORCID http://orcid.org/0000-0001-5497-0465

Funding

Frequency of variants of unknown significance by ancestry groups in the All of Us Research Program cohortU01HG011758 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI RICHARD A GIBBS, JAMES R. LUPSKI · 2021 to 2026
$13.8M
STRUCTURAL VARIATION IN NEUROLOGICAL DISEASER35NS105078 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 2018 to 2025
$6.0M
Agence Nationale de la Recherche (French National Research Agency) 22-RAR4-0001-01Agence Nationale de la Recherche (French National Research Agency) ANR-21-CE17-0005AXA Research Fund (Le Fonds AXA pour la Recherche) TND-UPSCentre Hospitalier Universitaire de Nantes (CHU de Nantes) PROG/09/72-03U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35 NS105078U.S. Department of Health & Human Services | National Institutes of Health (NIH) U01 HG011758
6 · The paper itself

Abstract

Poly(rC)-binding protein 1 (PCBP1), a splicing factor and key member of the hnRNP E family, was initially characterized for its tumor suppressive properties. More recently, its role in gene regulation in the brain and nervous system has attracted growing interest. Through an international multicenter collaboration, we identified 16 de novo pathogenic variants in PCBP1 across 17 subjects from 16 unrelated families. All affected individuals exhibited intellectual disability (ID), with autism spectrum disorder (ASD) as a prominent feature. Functional analysis in primary hippocampal mouse neuron cultures indicated that PCBP1 variants impair dendritic arborization, underscoring their deleterious effects. Transcriptomic profiling by RNA sequencing of subject-derived T cells showed a distinctive signature characterized by significantly increased exon skipping. These results highlight the contribution of PCBP1 in neurogenesis and neuritogenesis, which is impacted by loss-of-function variants expressed in neuronal cells, thereby supporting the link between splicing defects and neurodevelopmental disorders. Collectively, our findings demonstrate the prominent role of PCBP1 in neurodevelopment, reaffirming the importance of splicing regulation in mammalian neurodevelopment.

Identifiers

PMID42749777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.